Amyloid, advanced glycation end products, and dialysis related arthropathy
- PMID: 9709172
- PMCID: PMC1752588
- DOI: 10.1136/ard.57.4.193
Amyloid, advanced glycation end products, and dialysis related arthropathy
Figures


Similar articles
-
New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.Nephrol Dial Transplant. 1996;11 Suppl 2:140-3. doi: 10.1093/ndt/11.supp2.140. Nephrol Dial Transplant. 1996. PMID: 8804015 Review. No abstract available.
-
Beta2-microglobulin and renal bone disease.Perit Dial Int. 1999;19 Suppl 2:S413-6. Perit Dial Int. 1999. PMID: 10406556 Review.
-
Dialysis arthropathy.Lancet. 1988 Jan 2-9;1(8575-6):27-8. Lancet. 1988. PMID: 2891893 No abstract available.
-
Beta 2-microglobulin-related amyloidosis: where do we stand?Nephrol Dial Transplant. 1995;10(2):155-7. Nephrol Dial Transplant. 1995. PMID: 7753446 No abstract available.
-
Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.Nephrol Dial Transplant. 1996;11 Suppl 3:86-90. doi: 10.1093/ndt/11.supp3.86. Nephrol Dial Transplant. 1996. PMID: 8840320 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical